In vitro products for drug discovery, adme-tox and transporter research
ReadyCell, Easing your Screening
The leading manufacturer of ready-to-use cell-based plates
Got a minute?
ReadyCell values your input! Take a quick survey and let us know your opinions on our services. Start the survey now!
Presenting the last advances in transporters in Germany
On May 15-17, the 22nd Barrier- and Transporter- days took place in Germany. At the event, Jonatan Cucala, R&D researcher at ReadyCell, presented a poster entitled “PreadyTake, an in vitro ready-to-use cell-based model to evaluate potential drug-transporter interactions.”
ReadyCell promotes continuous learning through in-house seminars
Last Thursday, R&D Director Lourdes Gombau presented “Women and Science”, a seminar that aimed to raise awareness of the role of women in the scientific field throughout history and at present.
MPS-LOC: Microphysiological systems based on liver on chip for drug discovery and testing
ReadyCell is partaking in a new collaborative project together with Leitat Technological Center and Vall d’Hebron Institute of Research (VHIR). The project aims to develop microphysiological systems based on liver-on-chip for drug discovery and testing.
Why evaluate MDR1 receptor affinity in CNS pharmacokinetic assays?
MDCKII cells based in vitro system is a recommended model to evaluate blood-brain barrier permeability during CNS action novel compounds.
Cytotoxicity Assay Protocol
Through this protocol we offer our CacoReady plates for assessing drug-associated gastrointestinal side effects.
StretchBio holds its 18-month meeting
Our representatives participated in the 18-month meeting of the StretchBio project, held in Freiburg. The meeting was focused on the design and operation of the functional prototype of the sensor.